Clinical Trials in Salt Lake City

Showing 9781-9800 of 16,694 trials

Placenta Imaging Project

NCT02749851

The purpose of this study is to test the application of newly generated magnetic resonance imaging (MRI) protocols for the assessment of placental perfusion in human subjects. The primary objective is to validate and establish the utility of placental MRI in pregnant women. The study will be entirely MRI-technology based with collection of placental tissue at the time of infant delivery for later correlative studies.

High Risk Pregnancy

Oregon Health and Science University379 participantsStarted Oct 2016

Portland, Oregon, United States • Salt Lake City, Utah, United States

UNKNOWN6.5 miles

Assessing AlloSure Dd-cfDNA Monitoring Insights of Renal Allografts With Longitudinal Surveillance

NCT04566055

Prospective Observational Multicenter Cohort. External validation of donor derived cell free DNA in Renal Transplantation. Assessing performance of dd-cfDNA as a surveillance tool and its association with clinical outcomes. Outcomes include formation of de-novo DSA, eGFR decline, performance of AlloSure dd-cfDNA in Allograft rejection.

Kidney Transplant Rejection

CareDx1,000 participantsStarted Mar 2019

Aurora, Colorado, United States • Tampa, Florida, United States • Baltimore, Maryland, United States +5 more locations

Placenta Imaging Project

Assessing AlloSure Dd-cfDNA Monitoring Insights of Renal Allografts With Longitudinal Surveillance

Find Trials by Condition in Salt Lake City

Immunogenicity and Safety of Tetravalent Dengue Vaccine (TDV) Administered With a Yellow Fever Vaccine in Adults

Iron Isomaltoside/Ferric Derisomaltose vs Iron Sucrose for the Treatment of Iron Deficiency Anemia (IDA)

Fludarabine, Pixantrone and Rituximab vs Fludarabine and Rituximab forRelapsed or Refractory Indolent NHL

Combination Chemotherapy With or Without Colony-stimulating Factors in Treating Women With Breast Cancer

Evaluation of Exufiber Ag+ and Other Gelling Fibre Dressings

A Safety and Efficacy Study of the Combination of VX-222 and Telaprevir in Treatment-Naïve Subjects With Genotype 1 Chronic Hepatitis C Virus Infection

Clinical Outcomes in Men With Prostate Cancer Who Selected Active Surveillance Using Prolaris® Testing

Erlotinib Hydrochloride With or Without Bevacizumab in Treating Patients With Stage IV Non-small Cell Lung Cancer With Epidermal Growth Factor Receptor Mutations

Pacritinib Versus Best Available Therapy to Treat Myelofibrosis

A Study of GDC-0853 in Participants With Refractory Chronic Spontaneous Urticaria (CSU).

Confirmation of Ventilation and Intubation by Determination With Ultrasonography

Safety of Sugammadex for the Reversal of Neuromuscular Blockade in American Society of Anesthesiologists (ASA) Class 3 or 4 Participants (MK-8616-145)

A Study of ARRY-520 and Bortezomib Plus Dexamethasone in Patients With Relapsed/Refractory Multiple Myeloma

Intravenous BI 836826 in Combination With Ibrutinib in Relapsed/Refractory CLL Patients Who Have Been Pre-treated With at Least One Prior Line of Systemic Therapy, and Who Are Eligible for Treatment With Ibrutinib

AVN944 in Combination With Gemcitabine for the Treatment of Pancreatic Cancer

Study of Rhopressa® for the Reduction of Elevated Intraocular Pressure in Patients With Glaucoma or Ocular Hypertension in a Real-world Setting

An Investigational Immuno-therapy Study to Determine the Safety of Urelumab Given in Combination With Nivolumab in Solid Tumors and B-cell Non-Hodgkin's Lymphoma

Single Arm on the Tolerability of Weekly Nab-paclitaxel